Both Chloroquine and Lopinavir/Ritonavir Are Ineffective for COVID-19 Treatment and Combined Worsen the Pathology: A Single-Center Experience with Severely Ill Patients

The off-label use of antiviral and antimalarial drugs has been considered by many researchers as a fast and relatively safe alternative to provide therapeutic options to treat COVID-19, but the assessment of such drug-specific effectiveness in this regard is far from complete. Especially, the curren...

Descripción completa

Detalles Bibliográficos
Autores principales: Sevilla-Castillo, Fernando, Roque-Reyes, Oscar J., Romero-Lechuga, Fernanda, Gómez-Núñez, Mario F., Castillo-López, Mariel, Medina-Santos, Diana, Román, Perla Oriana, Flores-Hernández, Jorge Rafael, Méndez-Coca, Juan Daniel, Montaño-Olmos, Daniela, Farfán-Lazos, Karla Cecilia, Tobón-Cubillos, Miranda, Viveros-Hernández, América, Torres-Ortega, Leonardo, Hernández-Skewes, Karla Y., Montiel-Bravo, Guillermo, Ortega-Rodríguez, Shannat, Peón, Alberto N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871110/
https://www.ncbi.nlm.nih.gov/pubmed/33732744
http://dx.doi.org/10.1155/2021/8821318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871110/
https://www.ncbi.nlm.nih.gov/pubmed/33732744
http://dx.doi.org/10.1155/2021/8821318

Ejemplares similares